BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18347668)

  • 1. Vascular biology of angiotensin and the impact of physical activity.
    Rush JW; Aultman CD
    Appl Physiol Nutr Metab; 2008 Feb; 33(1):162-72. PubMed ID: 18347668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II--receptor subtypes characterization and pathophysiological implications.
    Gulati K; Lall SB
    Indian J Exp Biol; 1996 Feb; 34(2):91-7. PubMed ID: 8641721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.
    Zhuo J; Moeller I; Jenkins T; Chai SY; Allen AM; Ohishi M; Mendelsohn FA
    J Hypertens; 1998 Dec; 16(12 Pt 2):2027-37. PubMed ID: 9886893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
    Li XC; Zhang J; Zhuo JL
    Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease.
    Adams V; Linke A; Kränkel N; Erbs S; Gielen S; Möbius-Winkler S; Gummert JF; Mohr FW; Schuler G; Hambrecht R
    Circulation; 2005 Feb; 111(5):555-62. PubMed ID: 15699275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
    Balakumar P; Jagadeesh G
    Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new look at the renin-angiotensin system--focusing on the vascular system.
    Nguyen Dinh Cat A; Touyz RM
    Peptides; 2011 Oct; 32(10):2141-50. PubMed ID: 21945916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition.
    Mombouli JV; Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S74-82. PubMed ID: 1282634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
    Meyer P; Flammer J; Lüscher TF
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
    Kurdi M; De Mello WC; Booz GW
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG; Donohue JA; Duket LH
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
    Landmesser U; Drexler H
    J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CNS renin-angiotensin system.
    von Bohlen und Halbach O; Albrecht D
    Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Protective Arm of Renin Angiotensin System; Recent Research Progress and Expectation for New Therapeutic Approach].
    Horiuchi M
    Nihon Rinsho; 2016 Sep; 74(9):1583-1589. PubMed ID: 30557497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The renin-angiotensin system: current data].
    Oudart N
    Ann Pharm Fr; 2005 Mar; 63(2):144-53. PubMed ID: 15976682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide.
    Gauthier KM; Zhang DX; Edwards EM; Holmes B; Campbell WB
    Endocrinology; 2005 Aug; 146(8):3319-24. PubMed ID: 15890772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptors.
    Dao VT; Medini S; Bisha M; Balz V; Suvorava T; Bas M; Kojda G
    Biochem Pharmacol; 2016 Jul; 112():24-36. PubMed ID: 27235748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel concept in the mechanism of injury and protection of gastric mucosa: role of renin-angiotensin system and active metabolites of angiotensin.
    Brzozowski T; Ptak-Belowska A; Kwiecien S; Krzysiek-Maczka G; Strzalka M; Drozdowicz D; Pajdo R; Olszanecki R; Korbut R; Konturek SJ; Pawlik WW
    Curr Med Chem; 2012; 19(1):55-62. PubMed ID: 22300076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular endothelial dysfunction].
    Ide N; Node K
    Nihon Rinsho; 2009 Apr; 67(4):701-6. PubMed ID: 19348231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.